Corona Remedies has informed that Annual General Meeting (AGM) of the Company was held on Thursday, July 09, 2026 through Video Conferencing / Other Audio Visual Means. The following resolutions as mentioned in the Notice of the 22nd AGM were passed through remote e-voting: To receive, consider and adopt the Audited Financial Statements (Standalone and Consolidated) of the Company for the financial year ended March 31, 2026 and the Reports of the Board of Directors and Auditors thereon for the financial year ended March 31, 2026; To declare final dividend of ?10 each (Rupees Ten each) (100%) per Equity Share having face value of ?10 each for the FY2025-26; To appoint a Director in place of Nirav Mehta (DIN: 01644041), who retires by rotation and being eligible, offers himself for re-appointment;. To appoint Walker Chandiok & Co LLP, Chartered Accountants, as the Statutory Auditors of the Company and to fix their remuneration; To ratify the remuneration payable to the Cost Auditors for the FY2026-27; To appoint Dhara Patel, Company Secretary Firm as Secretarial Auditors of the Company; To approve payment of commission to the Non Executive Directors of the Company; To approve payment of remuneration to Dr. Kirtikumar Mehta (DIN: 00385658), Non Executive Director and Chairman of the Company for the Financial Year 2026-27; Re-appointment of Dr. Kirtikumar Mehta (DIN: 00385658) as Non Executive Director and Chairman of the Company for a term of 5 years.
The above information is a part of company’s filings submitted to BSE.
